The role of angiopoietin-1 and thrombospondin-1 in the kidney of rats subject to 5/6 nephrectomy

Abstract

The expression of angiopoietin-1 (Ang-1) and thrombospondin-1 (TSP-1) in 5/6 subtotal nephrectomy (STN) rats model, and its correlation to the renal microvasculature injury were investigated. Rat 5/6 STN model was established in adult male SD rats, and the sham-operated group and 5/6 STN group were set up. The renal function and histopathological changes were examined at the 1st, 2nd, 4th, 8th and 12th week after operation. The expression of Ang-1, TSP-1 and CD31 in renal tissues was detected by using immunohistochemistry. From 2nd to 8th week after operation, Ang-1 was significantly expressed in glomeruli of rats with STN. Ang-1 staining in glomeruli of STN group was increased significantly as compared with that in sham-operated group at 4th and 8th week after operation, and subsequently decreased after the 12th week. The expression of TSP-1 was increased significantly in STN group. As compared with sham-operated group, the CD31 expression was significantly down-regulated from the 2nd week. The expression of Ang-1 mRNA was detected by using RT-PCR at the same time points. The expression of Ang-1 mRNA in renal tissue of rats with STN was significantly up-regulated at the 2nd, 4th and 8th week after operation as compared with that in STN group at other time points or in sham-operated group at the same time points, while decreased evidently at the 12th week as compared with that in sham-operated group. It is concluded that there are changes in the mRNA expression of Ang-1, and the significant up-regulation of the expression of TSP-1 in renal tissue of rats with STN, which may be involved in the remnant renal microvasculature injury.

Keywords

5/6 nephrectomy / angiopoietin-1 / thrombospondin-1 / CD31 / microvasculature injury

References

[1] NegriA.L.. Prevention of progressive fibrosis in chronic renal diseases: antifibrotic agents. J Nephrol, 2004, 17(4): 496-503

[2] UchimuraH., MarumoT., TakaseO., et al.. Intrarenal injection of bone marrow-derived angiogenic cells reduces endothelial injury and mesangial cell activation in experimental glomerulonephritis. J Am Soc Nephrol, 2005, 16(4): 997-1004

[3] DardikR., SolomonA., LoscalzoJ., et al.. Novel proangiogenic effect of factor XIII associated with suppression of thrombospondin 1 expression. Arterioscler Thromb Vasc Biol, 2003, 23(8): 1472-1477

[4] KangD.H., KanellisJ., HugoC., et al.. Role of themicrovascular endothelium in progressive renal disease. J Am Soc Nephrol, 2002, 13(3): 806-816

[5] KangD.H., JolyA.H., OhS.W., et al.. Impaired angiogenesis in the remnant kidney model: potential role of vascular endothelial growth factor and thrombospondin-1. J Am Soc Nephrol, 2001, 12(7): 1434-1447

[6] ReindersM.E., RabelinkT.J., BriscoeD.M.. Angiogenesis and endothelial cell repair in renal disease and allograft rejection. J Am Soc Nephrol, 2006, 17(4): 932-942

[7] KangD.H., HughesJ., MazzaliM., et al.. Impaired angiogenesis in the remnant kidney model (II): VEGF administration reduces renal fibrosis and stabilizes renal function. J Am Soc Nephrol, 2001, 12(7): 1448-1457

[8] KangD.H., KanellisJ., HugoC., et al.. Role of endothelium in progressive renal disease. J Am Soc Nephrol, 2002, 13(3): 806-816

[9] KangD.H., AndersonS., KimY.G., et al.. Impaired angiogenesis in the aging kidney: vascular endothelial growth factor and thrombospondin-1 in renal disease. Am J Kidney Dis, 2001, 37(3): 601-611

[10] GaleN.W., YancopoulosG.D.. Growth factors acting via endothelial cell-specific receptor kinases: VEGFs, angiopoietins, and ephrins in vascular development. Genes Dev, 1999, 13(9): 1055-1066

[11] ArdeltA.A., McCulloughL.D., KorachK.S., et al.. Estradiol regulates angiopoietin-1 mRNA expression through estrogen receptor-alpha in a rodent experimental stroke model. Stroke, 2005, 36(2): 337-341

[12] ThurstonG.. Complementary actions of VEGF and angiopoietin-1 on blood vessel growth and leakage. J Anat, 2002, 200(6): 575-580

[13] RobertB., AbrahamsonD.R.. Control of glomerular capillary development by growth factor/receptor kinases. Pediatr Nephrol, 2001, 16(3): 294-301

[14] HaasC.S., CâmpeanV., KuhlmannA., et al.. Analysis of glomerular VEGF mRNA and protein expression in murine mesangioproliferative glomerulonephritis. Virchows Arch, 2007, 450(1): 81-92

[15] MasudaY., ShimizuA., MoriT., et al.. Vascular endothelial growth factor enhances glomerular capillary repair and accelerates resolution of experimentally induced glomerulonephritis. Am J Pathol, 2001, 159(2): 599-608

[16] YuanH.T., TippingP.G., LiX.Z., et al.. Angiopoietin correlates with glomerular capillary loss in anti-glomerular basement membrane glomerulonephritis. Kidney Int, 2002, 61(6): 2078-2089

[17] LongD.A., WoolfA.S., SudaT., et al.. Increased renal angiopoietin-1 expression in folic acid-induced nephrotoxicity in mice. J Am Soc Nephrol, 2001, 12(12): 2721-2731

[18] ZhouQ., GouP., GalloJ.M.. Impact of angiogenesis inhibition by sunitinib on tumor distribution of temozolomide. Clin Cancer Res, 2008, 14(5): 1540-1549

[19] KitamuraH., ShimizuA., MasudaY., et al.. Apoptosis in glomerular endothelial cells during the development of glomerulosclerosis in the remnant kidney model. Exp Nephrol, 1998, 6(4): 328-336

[20] SatchellS.C., AndersonK.L., MathiesonP.W.. Angiopoietin-1 and vascular endothelial growth factor modulate human glomerular endothelial cell barrier properties. J Am Soc Nephrol, 2004, 15(3): 566-574

[21] PizurkiL., ZhouZ., GlynosK., et al.. Angiopoietin-1 inhibits endothelial permeability, neutrophil adherence and IL-8 production. Br J Pharmacol, 2003, 139(2): 329-336

[22] KimW., MoonS.O., LeeS.Y., et al.. COMP-Angiopoietin-1 ameliorates renal fibrosis in a unilateral ureteral obstruction model. J Am Soc Nephrol, 2006, 17(9): 2474-2483